Tandem Diabetes Care
TNDM
90 hedge funds and large institutions have $238M invested in Tandem Diabetes Care in 2015 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 36 increasing their positions, 11 reducing their positions, and 8 closing their positions.
300% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 8
227% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 11
49% more capital invested
Capital invested by funds: $160M → $238M (+$77.8M)
36% more funds holding
Funds holding: 66 → 90 (+24)
99% less call options, than puts
Call options by funds: $6K | Put options by funds: $1.11M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$21M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
+$8.91M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$8.7M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.45M |
| 5 |
Millennium Management
New York
|
+$7.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$8.89M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$6.29M |
| 3 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$4.08M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$1.27M |
| 5 |
Goldman Sachs
New York
|
-$1.01M |
TNDM Hedge Fund Activity: Q1 2015 in Review
90 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q1 2015, worth a combined $238M — up 49% from $160M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new TNDM positions and 8 closed out — a net gain of 24 holders — while 36 added to existing stakes and 11 trimmed.
The largest buyer was Frontier Capital Management, opening a new position worth an estimated $21M. The largest seller was Jennison Associates, exiting entirely with an estimated $8.89M sold.
- 90 institutional investors held Tandem Diabetes Care (TNDM) as of Q1 2015, up from 66 in Q4 2014.
- Funds reported $238M of Tandem Diabetes Care stock for Q1 2015, up 49% quarter-over-quarter.
- 32 funds opened new Tandem Diabetes Care positions in Q1 2015 and 8 closed out, a net change of +24 holders.
- The largest Tandem Diabetes Care buyer in Q1 2015 was Frontier Capital Management, an estimated $21M added.
- The largest Tandem Diabetes Care seller in Q1 2015 was Jennison Associates, an estimated $8.89M sold.
Based on aggregated 13F filings for Q1 2015.